Applied Genetic Technologies Corp (AGTC)


Stock Price Forecast

Dec. 1, 2022


Forecasted Returns

7 Days Predict

30 Days Predict

90 Days Predict


Forecasted Market-Excess Returns

7 Days Predict

30 Days Predict

90 Days Predict

Loading Applied Genetic Technologies Corp chart...

About the Company

Applied Genetic Technologies Corp. (AGTC) is a clinical-stage biotechnology company developing genetic therapies for people with rare and debilitating ophthalmic, otologic and central nervous system (CNS) diseases. AGTC is a leader in designing and constructing all critical gene therapy elements and bringing them together to develop customized therapies that address real patient needs. AGTC's most advanced clinical programs leverage its best-in-class technology platform to potentially improve vision for patients with an inherited retinal disease. AGTC has active clinical trials in X-linked retinitis pigmentosa (XLRP) and achromatopsia (ACHM CNGB3 and ACHM CNGA3). Its preclinical programs build on the Company's industry leading AAV manufacturing technology and scientific expertise. AGTC is advancing multiple important pipeline candidates to address substantial unmet clinical need in optogenetics, otology and CNS disorders. In recent years AGTC has entered into strategic partnerships with companies including Otonomy, a biopharmaceutical company dedicated to the development of innovative therapeutics for neurotology, and Bionic Sight, an innovator in the emerging field of optogenetics and retinal coding.

CEO

Susan Washer

Exchange

NASDAQ

Website

www.agtc.com

$25M

Total Revenue

83

Employees

$27M

Market Capitalization

-0.25

Price/Earning ratio

Fundamental Data and Insider Transactions (Quarterly data) Full Screen

Loading the fundamentals chart...

Latest $AGTC News

Revolutionizing Cancer Detection: New Machine Learning Method Deciphers Genomic “Dark Matter”

2d ago, source:

Identifying and characterizing repeated DNA sequences, sometimes called "junk DNA" or "dark matter" within chromosomes, which ...

Woman in 50-year-old Ledyard murder case identified

5d ago, source: The Day

Ledyard ― For the past 50 years, one of the two murder victims found shot in the head and buried in a shallow grave off ...

Applied DNA to Showcase Linea(TM) DNA and Linea(TM) IVT Platforms at 24th Annual World Vaccine Congress

4d ago, source:

STONY BROOK, NY / ACCESSWIRE / March 14, 2024 / (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, will showcase its Linea™ IVT and Linea™ DNA platforms at the 24th Annual World ...

UW-Madison botany professor is breaking new ground in the science of space gardening

18h ago, source:

UW-Madison botany professor Simon Gilroy and his research team are conducting their sixth plant expedition into space, ...

Applied Molecular Transport files patent for oral delivery of therapeutic payload using carrier-payload complex

6d ago, source: Pharmaceutical Technology

Discover the innovative patent by Applied Molecular Transport Inc. for efficient delivery of therapeutic payloads using carrier-payload complexes derived from Cholix polypeptides. Explore the ...

SLAS2024: conference report

6d ago, source: BioTechniques

International Conference and Exhibition returned to Boston this year, taking place 3-7 February. Fulfilling its tagline, ...

Mass spectrometry and glycobiology - what are the genetic applications?

12d ago, source: News Medical

My focus within glycobiology has been skewed more toward the applied ... technology has finally caught up with it. Early in my career, mass spectrometry was something I never imagined myself doing. I ...

SOPHiA GENETICS and The French Kidney Cancer Research Network (UroCCR) Publish Results from Multiyear Collaboration

3d ago, source: TMCnet

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, and the French Kidney ...

Tome Biosciences Forms Science and Technology Advisory Committee

14d ago, source:

PGI is a brand name and technology of Tome Biosciences, Inc. For media: CG Life CGL.TomeBio@cglife.com For investors: Michelle Avery, PhD, SVP, Corporate Affairs investors@tome.bio ...

AI model developed by SOPHiA GENETICS and UroCCR predicts post-operative outcomes in kidney cancer study

3d ago, source: News Medical on MSN

SOPHiA GENETICS (Nasdaq: SOPH), a cloud-native software company and a leader in data-driven medicine, and the French Kidney ...

Applied DNA Sciences, Inc.: Applied DNA to Showcase Linea DNA and Linea IVT Platforms at 24th Annual World Vaccine Congress

4d ago, source:

STONY BROOK, NY / ACCESSWIRE / March 14, 2024 / Applied DNA Sciences, Inc. (NASDAQ:APDN) (Applied DNA), a leader in PCR-based DNA technologies, will showcase its Linea IVT and Linea DNA platforms at t ...

Latest Neutral (free) Forecasts

STRONG BUY BUY NEUTRAL SELL STRONG SELL ALL

Loading the latest forecasts...

My Portfolio

Loading your portfolio...